4th Quarter - Report

VENABLE LLP for BIG CITIES HEALTH COALITION

Firm
Client
Income
$20,000
Expenses
—

What was lobbied

4 issue areas, each in the filer's own words, with who lobbied on it and where.

Tobacco TOB

FDA regulation of tobacco, nicotine, and synthetic nicotine; Banning menthol cigarettes and flavored cigars.

LobbyistCovered position, as disclosed
LAURA A HANEN —

Alcohol and Drug Abuse ALC

Substance use prevention, including naloxone, harm reduction, and Medication for Opioid Use Disorder; Elimination of X waiver; H.R. 1384/S. 445 - Mainstreaming Addiction Treatment Act; Delay Fentanyl scheduling as Schedule 1; S. 5167 TEST Act.

LobbyistCovered position, as disclosed
LAURA A HANEN —

Contacted: Centers For Disease Control & Prevention (CDC); SENATE; HOUSE OF REPRESENTATIVES

Bills named: S. 445 (117th), H.R. 1384 (117th), S. 5167 (117th)

Health Issues HCR

Public health data authority; H.R. 9476 Protecting America from Seasonal and Pandemic Influenza.

LobbyistCovered position, as disclosed
LAURA A HANEN —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: H.R. 9476 (117th)

Budget/Appropriations BUD

FY 2023 Labor-HHS-Education Appropriations bill; CDC funding for Advanced Molecular Detection, immunization, smoking and health, social determinants of health, violence prevention, public health preparedness, Epi and Lab capacity, data modernization initiative, infectious disesases, opioid prevention, climate and health, public health workforce, public health capacity and infrastructure; Teen Pregnancy Prevention Program and Adolescent, School Health program and Title X; HRSA funding; FY2023 Supplemental Funding for Monkeypox and COVID.

LobbyistCovered position, as disclosed
LAURA A HANEN —

Contacted: HOUSE OF REPRESENTATIVES; SENATE; Office of Management & Budget (OMB)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.